Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2018, Article ID 9793850, 6 pages
https://doi.org/10.1155/2018/9793850
Research Article

Positive Antithyroid Antibodies and Nonsuppressed TSH Are Associated with Thyroid Cancer: A Retrospective Cross-Sectional Study

13rd Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 1, 128 08 Praha 2, Czech Republic
2Dialectology Center, Institute of Clinical and Experimental Medicine, Vídeňská 1958, 140 21 Praha 4, Czech Republic
3Department of ENT, Surgery of Head and Neck, Na Homolce Hospital, Roentgenova 2/37, 150 00 Praha 5, Czech Republic

Correspondence should be addressed to Jan Krátký; zc.nfv@yktark.naj

Received 12 February 2018; Accepted 9 May 2018; Published 6 September 2018

Academic Editor: Christian-Heinz Anderwald

Copyright © 2018 Jan Krátký et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Davies and H. G. Welch, “Current thyroid cancer trends in the United States,” JAMA Otolaryngology–Head & Neck Surgery, vol. 140, no. 4, pp. 317–322, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Aschebrook-Kilfoy, M. H. Ward, M. M. Sabra, and S. S. Devesa, “Thyroid cancer incidence patterns in the United States by histologic type, 1992–2006,” Thyroid, vol. 21, no. 2, pp. 125–134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. D. S. A. McLeod and D. S. Cooper, “The incidence and prevalence of thyroid autoimmunity,” Endocrine, vol. 42, no. 2, pp. 252–265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. P. J. Vanderpump and W. M. G. Tunbridge, “Epidemiology and prevention of clinical and subclinical hypothyroidism,” Thyroid, vol. 12, no. 10, pp. 839–847, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Balkwill and A. Mantovani, “Inflammation and cancer: back to Virchow?” The Lancet, vol. 357, no. 9255, pp. 539–545, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. E. Dailey, S. Lindsay, and R. Skahen, “Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland,” Archives of Surgery, vol. 70, no. 2, pp. 291–297, 1955. View at Publisher · View at Google Scholar · View at Scopus
  7. E. S. Kim, D. J. Lim, K. H. Baek et al., “Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules,” Thyroid, vol. 20, no. 8, pp. 885–891, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Zhang, H. Li, Q. H. Ji et al., “The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease,” BMC Cancer, vol. 12, no. 1, p. 610, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. H. Lee, Y. Kim, J. W. Choi, and Y. S. Kim, “The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis,” European Journal of Endocrinology, vol. 168, no. 3, pp. 343–349, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Azizi, J. M. Keller, M. Lewis et al., “Association of Hashimoto’s thyroiditis with thyroid cancer,” Endocrine-Related Cancer, vol. 21, no. 6, pp. 845–852, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Liu, L. Zhu, D. Cui et al., “Coexistence of histologically confirmed Hashimoto’s thyroiditis with different stages of papillary thyroid carcinoma in a consecutive Chinese cohort,” International Journal of Endocrinology, vol. 2014, Article ID 769294, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Fiore, T. Rago, M. Scutari et al., “Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases,” Journal of Endocrinological Investigation, vol. 32, no. 4, pp. 344–351, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Gabalec, L. Srbova, M. Nova et al., “Impact of Hashimoto’s thyroiditis, TSH levels, and anti-thyroid antibody positivity on differentiated thyroid carcinoma incidence,” Endokrynologia Polska, vol. 67, no. 1, pp. 48–53, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. E. S. Cibas, S. Z. Ali, and NCI Thyroid FNA State of the Science Conference, “The Bethesda system for reporting thyroid cytopathology,” American Journal of Clinical Pathology, vol. 132, no. 5, pp. 658–665, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. B. R. Haugen, E. K. Alexander, K. C. Bible et al., “2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 26, no. 1, pp. 1–133, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Bongiovanni, A. Spitale, W. C. Faquin, L. Mazzucchelli, and Z. W. Baloch, “The Bethesda system for reporting thyroid cytopathology: a meta-analysis,” Acta Cytologica, vol. 56, no. 4, pp. 333–339, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Shu, G. E. Plautz, J. C. Krauss, and A. E. Chang, “Tumor immunology,” JAMA, vol. 278, no. 22, pp. 1972–1981, 1997. View at Publisher · View at Google Scholar
  18. L. L. Cunha, R. C. Ferreira, M. A. Marcello, J. Vassallo, and L. S. Ward, “Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer,” Journal of Thyroid Research, vol. 2011, Article ID 387062, 13 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Muzza, D. Degl’Innocenti, C. Colombo et al., “The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies,” Clinical Endocrinology, vol. 72, no. 5, pp. 702–708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. A. Tam, C. Kaya, F. B. M. Kılıç, R. Ersoy, and B. Çakır, “Thyroid nodules and thyroid cancer in Graves’ disease,” Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 58, no. 9, pp. 933–938, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Belfiore, D. Russo, R. Vigneri, and S. Filetti, “Graves’ disease, thyroid nodules and thyroid cancer,” Clinical Endocrinology, vol. 55, no. 6, pp. 711–718, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Boelaert, J. Horacek, R. L. Holder, J. C. Watkinson, M. C. Sheppard, and J. A. Franklyn, “Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 11, pp. 4295–4301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Fiore, T. Rago, M. A. Provenzale et al., “Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role,” Endocrine-Related Cancer, vol. 16, no. 4, pp. 1251–1260, 2009. View at Publisher · View at Google Scholar · View at Scopus